194 related articles for article (PubMed ID: 16551781)
1. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.
Wu ZL; Sohl CD; Shimada T; Guengerich FP
Mol Pharmacol; 2006 Jun; 69(6):2007-14. PubMed ID: 16551781
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.
Wang K; Guengerich FP
Chem Res Toxicol; 2012 Aug; 25(8):1740-51. PubMed ID: 22734839
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities.
Gillam EM; Guo Z; Ueng YF; Yamazaki H; Cock I; Reilly PE; Hooper WD; Guengerich FP
Arch Biochem Biophys; 1995 Mar; 317(2):374-84. PubMed ID: 7893152
[TBL] [Abstract][Full Text] [Related]
6. Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5.
Hosny G; Roman LJ; Mostafa MH; Masters BS
Arch Biochem Biophys; 1999 Jun; 366(2):199-206. PubMed ID: 10356284
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of recombinant human neutrophil leukotriene B4 omega-hydroxylase (cytochrome P450 4F3).
Kikuta Y; Kusunose E; Sumimoto H; Mizukami Y; Takeshige K; Sakaki T; Yabusaki Y; Kusunose M
Arch Biochem Biophys; 1998 Jul; 355(2):201-5. PubMed ID: 9675028
[TBL] [Abstract][Full Text] [Related]
8. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bacterial expression of several mammalian cytochrome P450s by codon optimization and chaperone coexpression.
Wu ZL; Qiao J; Zhang ZG; Guengerich FP; Liu Y; Pei XQ
Biotechnol Lett; 2009 Oct; 31(10):1589-93. PubMed ID: 19557307
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.
Soucek P
Arch Biochem Biophys; 1999 Oct; 370(2):190-200. PubMed ID: 10510277
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
12. Temperature effect on the functional expression of human cytochromes P450 2A6 and 2E1 in Escherichia coli.
Yim SK; Ahn T; Jung HC; Pan JG; Yun CH
Arch Pharm Res; 2005 Apr; 28(4):433-7. PubMed ID: 15918516
[TBL] [Abstract][Full Text] [Related]
13. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.
Kempf AC; Zanger UM; Meyer UA
Arch Biochem Biophys; 1995 Aug; 321(2):277-88. PubMed ID: 7646052
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
[TBL] [Abstract][Full Text] [Related]
15. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
Sandhu P; Baba T; Guengerich FP
Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
[TBL] [Abstract][Full Text] [Related]
17. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
18. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties.
Guo Z; Gillam EM; Ohmori S; Tukey RH; Guengerich FP
Arch Biochem Biophys; 1994 Aug; 312(2):436-46. PubMed ID: 8037457
[TBL] [Abstract][Full Text] [Related]
19. Heterologous expression, purification, and properties of human cytochrome P450 27C1.
Wu ZL; Bartleson CJ; Ham AJ; Guengerich FP
Arch Biochem Biophys; 2006 Jan; 445(1):138-46. PubMed ID: 16360114
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
